Analysen von Richard Vosser
| 25.02.21 | Bayer Neutral | JP Morgan Chase & Co. | |
| 15.02.21 | Roche Neutral | JP Morgan Chase & Co. | |
| 12.02.21 | Sanofi overweight | JP Morgan Chase & Co. | |
| 10.02.21 | Roche Neutral | JP Morgan Chase & Co. | |
| 09.02.21 | Merck overweight | JP Morgan Chase & Co. | |
| 08.02.21 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
| 08.02.21 | Sanofi overweight | JP Morgan Chase & Co. | |
| 05.02.21 | Sanofi overweight | JP Morgan Chase & Co. | |
|
Werbung
|
|||
| 03.02.21 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
| 03.02.21 | Novartis Underweight | JP Morgan Chase & Co. | |
| 03.02.21 | Merck overweight | JP Morgan Chase & Co. | |
| 02.02.21 | Bayer Neutral | JP Morgan Chase & Co. | |
| 29.01.21 | Sartorius Stedim Biotech overweight | JP Morgan Chase & Co. | |
| 29.01.21 | Sartorius vz. overweight | JP Morgan Chase & Co. | |
| 28.01.21 | Roche Neutral | JP Morgan Chase & Co. | |
| 27.01.21 | Sartorius vz. overweight | JP Morgan Chase & Co. | |
| 27.01.21 | Sanofi overweight | JP Morgan Chase & Co. | |
| 26.01.21 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
| 25.01.21 | Roche Neutral | JP Morgan Chase & Co. | |
| 21.01.21 | Sartorius vz. overweight | JP Morgan Chase & Co. | |
| 21.01.21 | Merck overweight | JP Morgan Chase & Co. | |
| 20.01.21 | Merck overweight | JP Morgan Chase & Co. | |
| 19.01.21 | Novartis Underweight | JP Morgan Chase & Co. | |
| 18.01.21 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
| 18.01.21 | Bayer Neutral | JP Morgan Chase & Co. | |
| 14.01.21 | Sanofi overweight | JP Morgan Chase & Co. | |
| 14.01.21 | Merck overweight | JP Morgan Chase & Co. | |
| 13.01.21 | Merck overweight | JP Morgan Chase & Co. | |
| 13.01.21 | Novartis Underweight | JP Morgan Chase & Co. | |
| 13.01.21 | Roche Neutral | JP Morgan Chase & Co. | |
| 04.01.21 | Sartorius vz. overweight | JP Morgan Chase & Co. | |
| 04.01.21 | GSK Neutral | JP Morgan Chase & Co. | |
| 04.01.21 | Bayer Neutral | JP Morgan Chase & Co. | |
| 04.01.21 | Novartis Underweight | JP Morgan Chase & Co. | |
| 04.01.21 | Novo Nordisk kaufen | JP Morgan Chase & Co. | |
| 04.01.21 | Sanofi overweight | JP Morgan Chase & Co. | |
| 04.01.21 | MorphoSys overweight | JP Morgan Chase & Co. | |
| 04.01.21 | Roche Neutral | JP Morgan Chase & Co. | |
| 04.01.21 | Merck overweight | JP Morgan Chase & Co. | |
| 21.12.20 | Roche overweight | JP Morgan Chase & Co. | |
| 07.12.20 | Roche overweight | JP Morgan Chase & Co. | |
| 01.12.20 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
| 24.11.20 | Sartorius vz. overweight | JP Morgan Chase & Co. | |
| 16.11.20 | Merck Neutral | JP Morgan Chase & Co. | |
| 12.11.20 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
| 12.11.20 | Merck Neutral | JP Morgan Chase & Co. | |
| 10.11.20 | Novartis Underweight | JP Morgan Chase & Co. | |
| 06.11.20 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
| 06.11.20 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
| 05.11.20 | Roche overweight | JP Morgan Chase & Co. | |